Article
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria
3 Dec 2014
Abstract excerpt
The application of afamelanotide, an α-melanocyte stimulating hormone agonistic analogue to protoporphyria, a disease with absolute sunlight-intolerance is discussed. The clinics, genetics and existing therapies of protoporphyria are described. The physiological receptor-mediated intracellular signaling of α-melanocyte stimulating hormone and effects of receptor variants are outlined. The pharmacological action...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
